文献速递细菌感染、耐药与抗菌药物医院感染防控

加拿大医院关键细菌病原体10年耐药趋势:CANWARD研究2007-16结果

Trends in antimicrobial resistance over 10 years among key bacterial pathogens from Canadian hospitals: results of the CANWARD study 2007-16.
PubMed 文献 · J Antimicrob Chemother · 2019-01-01

CANWARD研究分析了2007至2016年加拿大医院每年贡献分离株的监测数据,采用单因素趋势检验和多因素回归模型(校正患者人口学效应)描述关键细菌病原体耐药趋势。结果显示大肠埃希菌和肺炎克雷伯菌对多种抗菌药物耐药比例显著上升,包括ESBL阳性菌株增加;铜绿假单胞菌对部分药物耐药下降但对美罗培南非敏感增加;金黄色葡萄球菌对部分药物非敏感下降而肺炎链球菌对部分药物非敏感上升。

要点

  • 大肠埃希菌和肺炎克雷伯菌对多种抗菌药物耐药比例显著上升,包括ESBL阳性菌株。
  • 肺炎克雷伯菌对碳青霉烯类耐药比例出现小幅但显著的增加。
  • 铜绿假单胞菌对环丙沙星等耐药下降,但对美罗培南非敏感比例上升。

核心结论

  • 2007至2016年加拿大最显著的耐药变化是肠杆菌科对多类抗菌药物耐药增加、ESBL阳性大肠埃希菌和肺炎克雷伯菌增加,以及碳青霉烯耐药肺炎克雷伯菌小幅但显著增加。

研究设计与样本

  • 分析CANWARD研究中2007至2016年每年均贡献分离株的站点纵向数据,采用单因素趋势检验和多因素回归模型校正患者人口学效应。

主要发现

  • 大肠埃希菌对超广谱头孢菌素、阿莫西林/克拉维酸、甲氧苄啶/磺胺甲噁唑和环丙沙星耐药比例显著增加。
  • 肺炎克雷伯菌对超广谱头孢菌素、阿莫西林/克拉维酸、甲氧苄啶/磺胺甲噁唑、环丙沙星和碳青霉烯类耐药比例增加。
  • 阴沟肠杆菌对头孢他啶和甲氧苄啶/磺胺甲噁唑耐药比例增加。
  • ESBL阳性大肠埃希菌和肺炎克雷伯菌(包括血流分离株)比例在2007至2016年间显著增加。
  • 铜绿假单胞菌对环丙沙星、头孢吡肟、黏菌素、阿米卡星和庆大霉素耐药比例下降,但对美罗培南非敏感比例增加;金黄色葡萄球菌对克拉霉素、克林霉素和甲氧苄啶/磺胺甲噁唑非敏感比例下降,肺炎链球菌对克拉霉素、克林霉素和强力霉素非敏感比例增加。

临床怎么用

  • 应关注肠杆菌科对多类抗菌药物耐药及ESBL阳性菌株的增加趋势,在经验性治疗中结合本地耐药监测数据选择药物。
  • 对肺炎克雷伯菌碳青霉烯耐药的小幅上升需保持监测,并关注铜绿假单胞菌对美罗培南非敏感增加的情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We sought to analyse 10 years of longitudinal surveillance data (2007-16) from the CANWARD study and describe emerging trends in antimicrobial resistance for key bacterial pathogens across Canada. METHODS: Longitudinal data from CANWARD study sites that contributed isolates every year from 2007 to 2016 were analysed to identify trends in antimicrobial resistance over time using univariate tests of trend and multivariate regression models to account for the effects of patient demographics. RESULTS: Statistically significant increases occurred in the proportion of Escherichia coli isolates resistant to extended-spectrum cephalosporins, amoxicillin/clavulanate, trimethoprim/sulfamethoxazole and ciprofloxacin. Similarly, the proportion of Klebsiella pneumoniae isolates resistant to extended-spectrum cephalosporins, amoxicillin/clavulanate, trimethoprim/sulfamethoxazole, ciprofloxacin and carbapenems increased during the study. The proportion of Enterobacter cloacae isolates resistant to ceftazidime and trimethoprim/sulfamethoxazole increased. The proportion of both ESBL-positive E. coli and K. pneumoniae (including bloodstream isolates) increased significantly between 2007 and 2016. A reduction in the proportion of Pseudomonas aeruginosa that were ciprofloxacin, cefepime, colistin, amikacin and gentamicin resistant and an increase in the proportion of P. aeruginosa isolates non-susceptible to meropenem were observed. The proportion of isolates of Staphylococcus aureus non-susceptible to clarithromycin, clindamycin and trimethoprim/sulfamethoxazole decreased over time while an increase in the proportion of isolates of Streptococcus pneumoniae non-susceptible to clarithromycin, clindamycin and doxycycline was observed. CONCLUSIONS: Increases in Enterobacteriaceae resistance to multiple classes of antimicrobials, increases in ESBL-positive E. coli and K. pneumoniae, and the small but significant increase in carbapenem-resistant K. pneumoniae were the most remarkable changes in antimicrobial resistance observed from 2007 to 2016 in Canada.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Lagacé-Wiens PRS, Adam HJ, Poutanen S, et al. Trends in antimicrobial resistance over 10 years among key bacterial pathogens from Canadian hospitals: results of the CANWARD study 2007-16. J Antimicrob Chemother. 2019. PMID: 31505648. doi:10.1093/jac/dkz284

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。